» Articles » PMID: 28208263

Visualization, Quantification, and Alignment of Spectral Drift in Population Scale Untargeted Metabolomics Data

Overview
Journal Anal Chem
Specialty Chemistry
Date 2017 Feb 18
PMID 28208263
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Untargeted liquid-chromatography-mass spectrometry (LC-MS)-based metabolomics analysis of human biospecimens has become among the most promising strategies for probing the underpinnings of human health and disease. Analysis of spectral data across population scale cohorts, however, is precluded by day-to-day nonlinear signal drifts in LC retention time or batch effects that complicate comparison of thousands of untargeted peaks. To date, there exists no efficient means of visualization and quantitative assessment of signal drift, correction of drift when present, and automated filtering of unstable spectral features, particularly across thousands of data files in population scale experiments. Herein, we report the development of a set of R-based scripts that allow for pre- and postprocessing of raw LC-MS data. These methods can be integrated with existing data analysis workflows by providing initial preprocessing bulk nonlinear retention time correction at the raw data level. Further, this approach provides postprocessing visualization and quantification of peak alignment accuracy, as well as peak-reliability-based parsing of processed data through hierarchical clustering of signal profiles. In a metabolomics data set derived from ∼3000 human plasma samples, we find that application of our alignment tools resulted in substantial improvement in peak alignment accuracy, automated data filtering, and ultimately statistical power for detection of metabolite correlates of clinical measures. These tools will enable metabolomics studies of population scale cohorts.

Citing Articles

[Alignment method for metabolite chromatographic peaks using an -acyl glycine retention index system].

Hao J, Chen Y, Wang Y, An N, Bai P, Zhu Q Se Pu. 2024; 42(2):159-163.

PMID: 38374596 PMC: 10877472. DOI: 10.3724/SP.J.1123.2023.07015.


Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension.

Alotaibi M, Harvey L, Nichols W, Pauciulo M, Hemnes A, Long T bioRxiv. 2024; .

PMID: 38328113 PMC: 10849469. DOI: 10.1101/2024.01.20.576474.


Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction.

Lau E, Roshandelpoor A, Zarbafian S, Wang D, Guseh J, Allen N Nat Commun. 2023; 14(1):7557.

PMID: 37985769 PMC: 10662264. DOI: 10.1038/s41467-023-43363-3.


Alignment of multiple metabolomics LC-MS datasets from disparate diseases to reveal fever-associated metabolites.

Nastase A, Barrett M, Cardenas W, Cordeiro F, Zambrano M, Andrade J PLoS Negl Trop Dis. 2023; 17(7):e0011133.

PMID: 37486920 PMC: 10399774. DOI: 10.1371/journal.pntd.0011133.


An epidemiological introduction to human metabolomic investigations.

Joshi A, Rahnavard A, Kachroo P, Mendez K, Lawrence W, Julian-Serrano S Trends Endocrinol Metab. 2023; 34(9):505-525.

PMID: 37468430 PMC: 10527234. DOI: 10.1016/j.tem.2023.06.006.


References
1.
Wehrens R, Hageman J, van Eeuwijk F, Kooke R, Flood P, Wijnker E . Improved batch correction in untargeted MS-based metabolomics. Metabolomics. 2016; 12:88. PMC: 4796354. DOI: 10.1007/s11306-016-1015-8. View

2.
Kaddurah-Daouk R, Kristal B, Weinshilboum R . Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 2008; 48:653-83. DOI: 10.1146/annurev.pharmtox.48.113006.094715. View

3.
Snowden S, Dahlen S, Wheelock C . Application of metabolomics approaches to the study of respiratory diseases. Bioanalysis. 2012; 4(18):2265-90. DOI: 10.4155/bio.12.218. View

4.
Patti G, Yanes O, Siuzdak G . Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012; 13(4):263-9. PMC: 3682684. DOI: 10.1038/nrm3314. View

5.
Gika H, Theodoridis G, Earll M, Snyder R, Sumner S, Wilson I . Does the mass spectrometer define the marker? A comparison of global metabolite profiling data generated simultaneously via UPLC-MS on two different mass spectrometers. Anal Chem. 2010; 82(19):8226-34. PMC: 2951889. DOI: 10.1021/ac1016612. View